Entering text into the input field will update the search result below

Pacira Pharmaceuticals beats by $0.03, misses on revenue

  • Pacira Pharmaceuticals (NASDAQ:PCRX): Q1 EPS of $0.23 beats by $0.03.
  • Revenue of $58.32M (+59.1% Y/Y) misses by $2.79M.
  • Press Release

Recommended For You

More Trending News

About PCRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PCRX--
Pacira BioSciences, Inc.